hexamethonium has been researched along with Spasmophilia in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prior, C | 1 |
| Breadon, EL | 1 |
| Lindsay, KE | 1 |
| Alves-do-Prado, W | 1 |
| Corrado, AP | 1 |
| Prado, WA | 1 |
2 other studies available for hexamethonium and Spasmophilia
| Article | Year |
|---|---|
Modulation by presynaptic adenosine A1 receptors of nicotinic receptor antagonist-induced neuromuscular block in the mouse.
Topics: Adenine; Animals; Enzyme Inhibitors; Hexamethonium; Mice; Mice, Inbred BALB C; Neuromuscular Blockad | 1997 |
Reversal by atropine of tetanic fade induced in cats by antinicotinic and anticholinesterase agents.
Topics: Animals; Atropine; Cats; Cholinesterase Inhibitors; Drug Interactions; Electric Stimulation; Female; | 1987 |